SG Americas Securities LLC Purchases Shares of 286 Atrion Co. (NASDAQ:ATRI)

SG Americas Securities LLC acquired a new position in Atrion Co. (NASDAQ:ATRI) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 286 shares of the medical instruments supplier’s stock, valued at approximately $108,000.

A number of other institutional investors and hedge funds also recently made changes to their positions in ATRI. FMR LLC boosted its stake in Atrion by 38.0% in the first quarter. FMR LLC now owns 69 shares of the medical instruments supplier’s stock worth $43,000 after buying an additional 19 shares in the last quarter. Citigroup Inc. lifted its stake in Atrion by 63.1% in the first quarter. Citigroup Inc. now owns 106 shares of the medical instruments supplier’s stock worth $67,000 after purchasing an additional 41 shares during the last quarter. Advisor Group Holdings Inc. purchased a new stake in Atrion during the fourth quarter valued at about $65,000. Royal Bank of Canada increased its holdings in shares of Atrion by 44.1% in the third quarter. Royal Bank of Canada now owns 134 shares of the medical instruments supplier’s stock worth $76,000 after buying an additional 41 shares during the period. Finally, Qube Research & Technologies Ltd bought a new stake in shares of Atrion in the 3rd quarter valued at about $60,000. Hedge funds and other institutional investors own 66.19% of the company’s stock.

Wall Street Analyst Weigh In

Separately, StockNews.com raised Atrion from a “sell” rating to a “hold” rating in a research note on Friday, March 1st.

Atrion Stock Up 4.3 %

Shares of ATRI opened at $402.35 on Friday. The stock has a market capitalization of $708.14 million, a P/E ratio of 36.48 and a beta of 0.60. Atrion Co. has a twelve month low of $274.98 and a twelve month high of $670.00. The firm has a fifty day simple moving average of $401.11 and a two-hundred day simple moving average of $365.20.

Atrion (NASDAQ:ATRI) last posted its earnings results on Thursday, February 29th. The medical instruments supplier reported $3.65 earnings per share for the quarter. Atrion had a net margin of 11.46% and a return on equity of 8.07%. The company had revenue of $43.58 million during the quarter.

Atrion Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 29th. Shareholders of record on Friday, March 15th were issued a $2.20 dividend. The ex-dividend date of this dividend was Thursday, March 14th. This represents a $8.80 annualized dividend and a yield of 2.19%. Atrion’s dividend payout ratio (DPR) is presently 79.78%.

Atrion Company Profile

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmic applications in the United States, Canada, Europe, and internationally. The company's fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments.